{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:08:41Z","timestamp":1784545721167,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["R-154-000-447-112"],"award-info":[{"award-number":["R-154-000-447-112"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012415","name":"Biomedical Research Council","doi-asserted-by":"publisher","award":["BMRC\/01\/1\/21\/18\/074"],"award-info":[{"award-number":["BMRC\/01\/1\/21\/18\/074"]}],"id":[{"id":"10.13039\/501100012415","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.ajpath.2012.05.022","type":"journal-article","created":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T08:48:20Z","timestamp":1342169300000},"page":"1056-1068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["ADAMTS5 Functions as an Anti-Angiogenic and Anti-Tumorigenic Protein Independent of Its Proteoglycanase Activity"],"prefix":"10.1016","volume":"181","author":[{"given":"Saran","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheila","family":"Sharghi-Namini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithya","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruowen","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2012.05.022_bib1","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","article-title":"Angiogenesis in life, disease and medicine","volume":"438","author":"Carmeliet","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2012.05.022_bib2","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm0603-653","article-title":"Angiogenesis in health and disease","volume":"9","author":"Carmeliet","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2012.05.022_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/sonc.2002.37263","article-title":"Role of angiogenesis in tumor growth and metastasis","volume":"29","author":"Folkman","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ajpath.2012.05.022_bib4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2012.05.022_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jnci\/82.1.4","article-title":"What is the evidence that tumors are angiogenesis dependent?","volume":"82","author":"Folkman","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajpath.2012.05.022_bib6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc1093","article-title":"Tumorigenesis and the angiogenic switch","volume":"3","author":"Bergers","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2012.05.022_bib7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04483","article-title":"Angiogenesis as a therapeutic target","volume":"438","author":"Ferrara","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2012.05.022_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd2115","article-title":"Angiogenesis: an organizing principle for drug discovery?","volume":"6","author":"Folkman","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ajpath.2012.05.022_bib9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrclinonc.2009.52","article-title":"Anticancer strategies involving the vasculature","volume":"6","author":"Heath","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ajpath.2012.05.022_bib10","doi-asserted-by":"crossref","first-page":"31493","DOI":"10.1074\/jbc.R109.052340","article-title":"A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms","volume":"284","author":"Apte","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2012.05.022_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/BJ20040424","article-title":"The ADAMTS metalloproteinases","volume":"386","author":"Porter","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.ajpath.2012.05.022_bib12","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00018-007-7486-z","article-title":"Thrombospondins in cancer","volume":"65","author":"Kazerounian","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ajpath.2012.05.022_bib13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.18632\/oncotarget.200","article-title":"Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors","volume":"1","author":"Taraboletti","year":"2010","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2012.05.022_bib14","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.2741\/3827","article-title":"The roles of ADAMTS metalloproteinases in tumorigenesis and metastasis","volume":"16","author":"Wagstaff","year":"2011","journal-title":"Front Biosci"},{"key":"10.1016\/j.ajpath.2012.05.022_bib15","doi-asserted-by":"crossref","first-page":"23349","DOI":"10.1074\/jbc.274.33.23349","article-title":"METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity","volume":"274","author":"Vazquez","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2012.05.022_bib16","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1242\/jcs.005751","article-title":"The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway","volume":"120","author":"Llamazares","year":"2007","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ajpath.2012.05.022_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.22203\/eCM.v015a02","article-title":"ADAMTS-5: the story so far","volume":"15","author":"Fosang","year":"2008","journal-title":"Eur Cell Mater"},{"key":"10.1016\/j.ajpath.2012.05.022_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbagen.2006.01.013","article-title":"Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTSs: comparative analyses with ADAMTS-5, -9, -16 and -18","volume":"1760","author":"Zeng","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ajpath.2012.05.022_bib19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.matbio.2011.05.004","article-title":"Emerging roles for ADAMTS5 during development and disease","volume":"30","author":"Kintakas","year":"2011","journal-title":"Matrix Biol"},{"key":"10.1016\/j.ajpath.2012.05.022_bib20","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature03417","article-title":"ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro","volume":"434","author":"Stanton","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2012.05.022_bib21","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nature03369","article-title":"Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis","volume":"434","author":"Glasson","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2012.05.022_bib22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.devcel.2009.09.008","article-title":"ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression","volume":"17","author":"McCulloch","year":"2009","journal-title":"Dev Cell"},{"key":"10.1016\/j.ajpath.2012.05.022_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.gep.2009.02.006","article-title":"Adamts5, the gene encoding a proteoglycan-degrading metalloprotease, is expressed by specific cell lineages during mouse embryonic development and in adult tissues","volume":"9","author":"McCulloch","year":"2009","journal-title":"Gene Expr Patterns"},{"key":"10.1016\/j.ajpath.2012.05.022_bib24","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1158\/1078-0432.CCR-0398-3","article-title":"Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma","volume":"10","author":"Porter","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2012.05.022_bib25","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1245\/s10434-011-1573-y","article-title":"Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations","volume":"18","author":"Kim","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajpath.2012.05.022_bib26","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1200\/JCO.2005.01.4944","article-title":"Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis","volume":"23","author":"Roman-Gomez","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2012.05.022_bib27","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.1133427","article-title":"The consensus coding sequences of human breast and colorectal cancers","volume":"314","author":"Sjoblom","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2012.05.022_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ijc.21258","article-title":"Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas","volume":"118","author":"Held-Feindt","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2012.05.022_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00401-005-1032-6","article-title":"Human glioblastomas overexpress ADAMTS-5 that degrades brevican","volume":"110","author":"Nakada","year":"2005","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2012.05.022_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbrc.2008.04.047","article-title":"The first but not the second thrombospondin type 1 repeat of ADAMTS5 functions as an angiogenesis inhibitor","volume":"371","author":"Sharghi-Namini","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2012.05.022_bib31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1582-4934.2009.00961.x","article-title":"Isthmin is a novel secreted angiogenesis inhibitor that inhibits tumor growth in mice","volume":"15","author":"Xiang","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ajpath.2012.05.022_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ajpath.2012.05.022_bib33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","article-title":"The biology of vascular endothelial growth factor","volume":"18","author":"Ferrara","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajpath.2012.05.022_bib34","first-page":"222","article-title":"Angiogenesis inhibitors: current strategies and future prospects","volume":"60","author":"Cook","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajpath.2012.05.022_bib35","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2012.05.022_bib36","doi-asserted-by":"crossref","first-page":"18294","DOI":"10.1074\/jbc.M701523200","article-title":"Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4","volume":"282","author":"Gendron","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2012.05.022_bib37","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biocel.2008.10.008","article-title":"Characterization of proADAMTS5 processing by proprotein convertases","volume":"41","author":"Longpre","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.ajpath.2012.05.022_bib38","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/sj.onc.1209287","article-title":"Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively","volume":"25","author":"Liu","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2012.05.022_bib39","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1007\/s00018-010-0431-6","article-title":"ADAMTS-2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity","volume":"67","author":"Dubail","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ajpath.2012.05.022_bib40","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1158\/0008-5472.CAN-09-4510","article-title":"Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis","volume":"70","author":"Lo","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2012.05.022_bib41","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.2353\/ajpath.2010.090655","article-title":"ADAMTS9 is a cell-autonomously acting, anti-angiogenic metalloprotease expressed by microvascular endothelial cells","volume":"176","author":"Koo","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2012.05.022_bib42","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2174\/138161209788682433","article-title":"A review of the ADAMTS family, pharmaceutical targets of the future","volume":"15","author":"Tortorella","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ajpath.2012.05.022_bib43","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0955-0674(00)00143-5","article-title":"The functions of thrombospondin-1 and-2","volume":"12","author":"Lawler","year":"2000","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.ajpath.2012.05.022_bib44","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.bbrc.2004.05.105","article-title":"The carboxyl-terminal half region of ADAMTS-1 suppresses both tumorigenicity and experimental tumor metastatic potential","volume":"319","author":"Kuno","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2012.05.022_bib45","doi-asserted-by":"crossref","first-page":"23656","DOI":"10.1074\/jbc.M212964200","article-title":"ADAMTS1\/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165","volume":"278","author":"Luque","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2012.05.022_bib46","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1016\/j.ajpath.2011.08.021","article-title":"The ADAMTS1 protease gene is required for mammary tumor growth and metastasis","volume":"179","author":"Ricciardelli","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2012.05.022_bib47","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2012.05.022_bib48","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1749-6632.2002.tb04870.x","article-title":"Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders","volume":"979","author":"Luttun","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.ajpath.2012.05.022_bib49","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.bcp.2007.05.008","article-title":"Targeting platelet-derived endothelial cell growth factor\/thymidine phosphorylase for cancer therapy","volume":"74","author":"Liekens","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ajpath.2012.05.022_bib50","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1538-7836.2007.02431.x","article-title":"Insulin-like growth factor binding protein-3 induces angiogenesis through IGF-I- and SphK1-dependent mechanisms","volume":"5","author":"Granata","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ajpath.2012.05.022_bib51","doi-asserted-by":"crossref","first-page":"10589","DOI":"10.1073\/pnas.0702031104","article-title":"IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth","volume":"104","author":"Lofqvist","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2012.05.022_bib52","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1096\/fj.04-1618fje","article-title":"Dual effects of IGFBP-3 on endothelial cell apoptosis and survival: involvement of the sphingolipid signaling pathways","volume":"18","author":"Granata","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2012.05.022_bib53","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/CMR.0b013e328343a1d6","article-title":"Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R","volume":"21","author":"Molhoek","year":"2011","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ajpath.2012.05.022_bib54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1096\/fj.01-0552com","article-title":"The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent","volume":"16","author":"Devy","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2012.05.022_bib55","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1038\/sj.onc.1207859","article-title":"Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth","volume":"23","author":"Bajou","year":"2004","journal-title":"Oncogene"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944012004269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944012004269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:36:54Z","timestamp":1757601414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944012004269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0002944012004269"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2012.05.022","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717976012.793470425","asserted-by":"object"}]},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADAMTS5 Functions as an Anti-Angiogenic and Anti-Tumorigenic Protein Independent of Its Proteoglycanase Activity","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2012.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2012.07.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}